## User

This is the beginning of an individual meeting with Medicinal Chemist to discuss your research project.

Here is context for this meeting:

[begin context 1]

ExperimentFluorescencePolarization[Samples]⟹Protocol

generates a Protocol for measuring fluorescence polarization of the provided Samples.



Fluorescence Polarization (FP) assesses the fraction of tracer bound to receptor by measuring the the molecular rotation of a fluorophore. The principle of FP is that a fluorophore excited by polarized light emits light oriented in a parallel plane. After a fluorescent molecule absorbs excitation light, it tumbles and rotates in solution during the time between excitation and emission. If the molecule is large, it rotates slowly, and the emission light remains largely polarized. Whereas a small, rapidly tumbling molecule rotates quickly and emits depolarized light. Measuring the degree of polarization provides a measure of the fraction of tracer bound to receptor, with applications in receptor-ligand binding, enzymatic degradation, and DNA hybridization studies.



Experimental Principles

Figure 1.1: Procedural overview of a Fluorescence Polarization experiment. Step 1: Samples are prepared in a reader-compatible shallow well plate. Step 2: Injection lines are cleaned and primed. Step 3: The assay plate is optionally held at a specified temperature. Step 4: Injection samples are dispensed into the assay plate. Step 5: The assay plate is shaken. Step 6: The plate reader excites samples with horizontally polarized light and measures emitted light in the horizontal and vertical planes. Large molecules rotate slower than small molecules and reflect more polarized light. Step 7: Optionally follow-up analysis, such as standard curve fitting, can be performed.



Instrumentation

PHERAstar FS

Model[Instrument, PlateReader, "id:01G6nvkKr3o7"]

Figure 2.1.1: The PHERAstar uses optic modules to package excitation and emission filters into a single package. This means wavelength combinations are restricted to those which already exist in the optic module. Up to five excitation/emission pairs can be recorded in a single experiment. Additionally, the PHERAstar supports dual emission so it's possible to record emission data at 2 different wavelengths simultaneously. The plate chamber can be heated up to 45°C and it can mix the plate at up to 700 RPM before and/or during the run. The reader has two 300μL syringe pump injectors which can be used for 0.5 - 300 μL injections of two unique samples at up to four time points during the run. There are two primary kinetics read modes. It can perform all readings, injections and mixing for a single well before moving onto the next well or it can read in cycles, reading all the assay wells in the plate again and again until the RunTime has been reached. The second mode is recommended for most assays, except those that use very fast kinetics.



Experiment Options

Optics

ExcitationWavelength

The wavelength(s) which should be used to excite fluorescence in the samples.

Default Value: Automatic

Pattern Description: Greater than or equal to 320 nanometers and less than or equal to 740 nanometers.

Programmatic Pattern: RangeP[320*Nanometer, 740*Nanometer] | Automatic

Index Matches to: ExcitationWavelength

EmissionWavelength

The wavelength(s) at which fluorescence emitted from the sample should be measured.

Default Value: Automatic

Pattern Description: Greater than or equal to 320 nanometers and less than or equal to 740 nanometers.

Programmatic Pattern: RangeP[320*Nanometer, 740*Nanometer] | Automatic

Index Matches to: ExcitationWavelength

DualEmissionWavelength

The wavelength at which fluorescence emitted from the sample should be measured with the secondary detector (simultaneous to the measurement at the emission wavelength done by the primary detector).

Default Value: Automatic

Pattern Description: Greater than or equal to 320 nanometers and less than or equal to 740 nanometers or Null.

Programmatic Pattern: (RangeP[320*Nanometer, 740*Nanometer] | Automatic) | Null

Index Matches to: ExcitationWavelength

Instrument

The plate reader used to measure fluorescence intensity.

Default Value: Automatic

Pattern Description: An object of type or subtype Model[Instrument, PlateReader] or Object[Instrument, PlateReader]

Programmatic Pattern: ObjectP[{Model[Instrument, PlateReader], Object[Instrument, PlateReader]}] | Automatic

General

Gain

The gain which should be applied to the signal reaching the primary detector. This may be specified either as a direct voltage, or as a percentage (which indicates that the gain should be set such that the AdjustmentSample fluoresces at that percentage of the instrument's dynamic range).

Default Value: Automatic

Default Calculation: If unspecified defaults to 90% if an adjustment sample is provided or if the instrument can scan the entire plate to determine gain. Otherwise defaults to 2500 Microvolt

Pattern Description: Greater than or equal to 1 microvolt and less than or equal to 4095 microvolts or greater than or equal to 1 percent and less than or equal to 95 percent.

Programmatic Pattern: (RangeP[1*Percent, 95*Percent] | RangeP[1*Microvolt, 4095*Microvolt]) | Automatic

Index Matches to: ExcitationWavelength

DualEmissionGain

The gain to apply to the signal reaching the secondary detector. This may be specified either as a direct voltage, or as a percentage relative to the AdjustmentSample option.

Default Value: Automatic

Pattern Description: Greater than or equal to 1 microvolt and less than or equal to 4095 microvolts or greater than or equal to 1 percent and less than or equal to 95 percent or Null.

Programmatic Pattern: ((RangeP[1*Percent, 95*Percent] | RangeP[1*Microvolt, 4095*Microvolt]) | Automatic) | Null

Index Matches to: ExcitationWavelength

AdjustmentSample

The sample which should be used to perform automatic adjustments of gain and/or focal height values at run time. The focal height will be set so that the highest signal-to-noise ratio can be achieved for the AdjustmentSample. The gain will be set such that the AdjustmentSample fluoresces at the specified percentage of the instrument's dynamic range. When multiple aliquots of the same sample is used in the experiment, an index can be specified to use the desired aliquot for adjustments.

Default Value: Automatic

Pattern Description: An object of type or subtype Object[Sample] or a prepared sample or {Index, Sample} or Null.

Programmatic Pattern: (((ObjectP[Object[Sample]] | _String) | {RangeP[1, 384, 1], ObjectP[Object[Sample]] | _String}) | Automatic) | Null

TargetPolarization

The target polarization value which should be used to perform automatic adjustments of gain and/or focal height values at run time on the chosen adjustment sample.

Default Value: Automatic

Pattern Description: Greater than or equal to 0 PolarizationUnits and less than or equal to 500 PolarizationUnits.

Programmatic Pattern: RangeP[0*PolarizationUnit, 500*PolarizationUnit] | Automatic

RetainCover

Indicates if the plate seal or lid on the assay container should not be taken off during measurement to decrease evaporation. When this option is set to True, injections cannot be performed as it's not possible to inject samples through the cover.

Default Value: False

Pattern Description: True or False.

Programmatic Pattern: BooleanP

ReadLocation

Indicates if fluorescence should be measured using an optic above the plate or one below the plate.

Default Value: Automatic

Default Calculation: Defaults to Bottom if RetainCover is set to True, otherwise defaults to Top.

Pattern Description: Top or Bottom.

Programmatic Pattern: ReadLocationP | Automatic

Temperature

The temperature at which the experiment will be performed, if using a plate reader with temperature incubation controls.

Default Value: Ambient

Pattern Description: Ambient or greater than or equal to 25 degrees Celsius and less than or equal to 45 degrees Celsius.

Programmatic Pattern: RangeP[$AmbientTemperature, 45*Celsius] | Ambient

EquilibrationTime

The length of time for which the assay plates should equilibrate at the assay temperature in the plate reader before being read.

Default Value: Automatic

Default Calculation: Defaults to 0 Second if Temperature is set to Ambient. Otherwise defaults to 5 Minute.

Pattern Description: Greater than or equal to 0 minutes and less than or equal to 1 hour.

Programmatic Pattern: RangeP[0*Minute, 1*Hour] | Automatic

NumberOfReadings

Number of redundant readings which should be taken by the detector to determine a single averaged fluorescence intensity reading.

Default Value: 100

Pattern Description: Greater than or equal to 1 and less than or equal to 200.

Programmatic Pattern: RangeP[1, 200]

FocalHeight

The distance from the bottom of the plate carrier to the focal point. If set to Automatic, the focal height will be adjusted based on the Gain adjustment, which will occur only if the gain values are set to percentages.

Default Value: Automatic

Pattern Description: Auto or greater than or equal to 0 millimeters and less than or equal to 25 millimeters or Null.

Programmatic Pattern: ((RangeP[0*Millimeter, 25*Millimeter] | Auto) | Automatic) | Null

WorkCell

Indicates the work cell that this primitive will be run on if Preparation->Robotic.

Default Value: Automatic

Default Calculation: Automatically set to STAR if Preparation->Robotic.

Pattern Description: STAR, bioSTAR, microbioSTAR, or qPix or Null.

Programmatic Pattern: (WorkCellP | Automatic) | Null

Preparation

Indicates if this unit operation is carried out primarily robotically or manually. Manual unit operations are executed by a laboratory operator and robotic unit operations are executed by a liquid handling work cell.

Default Value: Automatic

Pattern Description: Manual or Robotic.

Programmatic Pattern: PreparationMethodP | Automatic

NumberOfReplicates

Number of times each of the input samples should be analyzed using identical experimental parameters.

Default Value: Null

Pattern Description: Greater than or equal to 2 in increments of 1 or Null.

Programmatic Pattern: GreaterEqualP[2, 1] | Null

Sample Handling

MoatSize

Indicates the number of concentric perimeters of wells which should be should be filled with MoatBuffer in order to decrease evaporation from the assay samples during the run.

Figure 3.1: Use the moat options, MoatBuffer, MoatVolume and MoatSize to create an outer ring of wells filled with buffer. This has been shown to decrease evaporation during long reads.

Default Value: Automatic

Pattern Description: Greater than 0 in increments of 1 or Null.

Programmatic Pattern: (GreaterP[0, 1] | Automatic) | Null

MoatVolume

Indicates the volume which should be added to each moat well.

Default Value: Automatic

Pattern Description: Greater than 0 microliters or Null.

Programmatic Pattern: (GreaterP[0*Microliter] | Automatic) | Null

MoatBuffer

Indicates the buffer which should be used to fill each moat well.

Default Value: Automatic

Pattern Description: An object of type or subtype Object[Sample] or Model[Sample] or a prepared sample or Null.

Programmatic Pattern: ((ObjectP[{Object[Sample], Model[Sample]}] | _String) | Automatic) | Null

PrimaryInjectionSample

The sample to be injected in the first round of injections in order to introduce a time sensitive reagent/sample into the plate before/during fluorescence measurement.

Default Value: Null

Pattern Description: An object of type or subtype Object[Sample] or Model[Sample] or a prepared sample or Null.

Programmatic Pattern: (ObjectP[{Object[Sample], Model[Sample]}] | _String) | Null

Index Matches to: experiment samples

SecondaryInjectionSample

The sample to be injected in the second round of injections.

Default Value: Null

Pattern Description: An object of type or subtype Object[Sample] or Model[Sample] or a prepared sample or Null.

Programmatic Pattern: (ObjectP[{Object[Sample], Model[Sample]}] | _String) | Null

Index Matches to: experiment samples

PrimaryInjectionVolume

The amount of the primary sample which should be injected in the first round of injections.

Default Value: Null

Pattern Description: Greater than or equal to 0.5 microliters and less than or equal to 300 microliters or Null.

Programmatic Pattern: RangeP[0.5*Microliter, 300*Microliter] | Null

Index Matches to: experiment samples

SecondaryInjectionVolume

The amount of the secondary sample which should be injected in the second round of injections.

Default Value: Null

Pattern Description: Greater than or equal to 0.5 microliters and less than or equal to 300 microliters or Null.

Programmatic Pattern: RangeP[0.5*Microliter, 300*Microliter] | Null

Index Matches to: experiment samples

PrimaryInjectionFlowRate

The speed at which to transfer injection samples into the assay plate in the first round of injections.

Default Value: Automatic

Default Calculation: Defaults to 300 Microliter/Second if primary injections are specified.

Pattern Description: 430 microliters per second, 400 microliters per second, 350 microliters per second, 300 microliters per second, 260 microliters per second, 220 microliters per second, 190 microliters per second, 170 microliters per second, 150 microliters per second, 135 microliters per second, 115 microliters per second, 100 microliters per second, 85 microliters per second, 65 microliters per second, or 50 microliters per second or Null.

Programmatic Pattern: (BMGFlowRateP | Automatic) | Null

SecondaryInjectionFlowRate

The speed at which to transfer injection samples into the assay plate in the second round of injections.

Default Value: Automatic

Default Calculation: Defaults to 300 Microliter/Second if secondary injections are specified.

Pattern Description: 430 microliters per second, 400 microliters per second, 350 microliters per second, 300 microliters per second, 260 microliters per second, 220 microliters per second, 190 microliters per second, 170 microliters per second, 150 microliters per second, 135 microliters per second, 115 microliters per second, 100 microliters per second, 85 microliters per second, 65 microliters per second, or 50 microliters per second or Null.

Programmatic Pattern: (BMGFlowRateP | Automatic) | Null

PlateReaderMix

Indicates if samples should be mixed inside the plate reader chamber.

Default Value: Automatic

Default Calculation: Automatically set to True if any other plate reader mix options are specified.

Pattern Description: True or False.

Programmatic Pattern: BooleanP | Automatic

PlateReaderMixTime

The amount of time samples should be mixed inside the plate reader chamber.

Default Value: Automatic

Default Calculation: Automatically set to 30 second if any other plate reader mix options are specified.

Pattern Description: Greater than or equal to 1 second and less than or equal to 1 hour or Null.

Programmatic Pattern: (RangeP[1*Second, 1*Hour] | Automatic) | Null

PlateReaderMixRate

The rate at which the plate should be agitated inside the plate reader chamber.

Default Value: Automatic

Default Calculation: Automatically set to 700 RPM if any other plate reader mix options are specified.

Pattern Description: Greater than or equal to 100 revolutions per minute and less than or equal to 700 revolutions per minute or Null.

Programmatic Pattern: (RangeP[100*RPM, 700*RPM] | Automatic) | Null

PlateReaderMixMode

The pattern of motion which should be employed to shake the plate.

Default Value: Automatic

Default Calculation: Automatically set to DoubleOrbital if any other plate reader mix options are specified.

Pattern Description: Orbital, DoubleOrbital, or Linear or Null.

Programmatic Pattern: (MechanicalShakingP | Automatic) | Null

ReadDirection

Indicates the order in which wells should be read by specifying the plate path the instrument should follow when measuring fluorescence.

Figure 3.2: Use the ReadDirection option to control how the plate reader scans the plate during each read cycle. Choosing a more efficient path will lead to a shorter DetectionInterval. Also note that you may want to consider dripping injectors if you're working with low viscosity injection samples.

Default Value: Row

Pattern Description: Row, Column, SerpentineRow, or SerpentineColumn.

Programmatic Pattern: ReadDirectionP

InjectionSampleStorageCondition

The non-default conditions under which any injection samples used by this experiment should be stored after the protocol is completed.

Default Value: Null

Pattern Description: {AmbientStorage, Refrigerator, Freezer, DeepFreezer, CryogenicStorage, YeastIncubation, BacteriaIncubation, MammalianIncubation, TissueCultureCellsIncubation, MicrobialCellsIncubation, MicrobialCellsShakingIncubation, YeastCellsIncubation, YeastCellsShakingIncubation, ViralIncubation, AcceleratedTesting, IntermediateTesting, LongTermTesting, UVVisLightTesting} or Disposal or Null.

Programmatic Pattern: (SampleStorageTypeP | Disposal) | Null

Sampling

SamplingPattern

Indicates where in the well measurements are taken.

Default Value: Automatic

Pattern Description: Matrix, Spiral, Ring, or Center.

Programmatic Pattern: PlateReaderSamplingP | Automatic

SamplingDistance

Indicates the length of the region over which sampling measurements are taken.

Default Value: Automatic

Default Calculation: Automatically resolves to Null if SamplingPattern is set to Center otherwise resolves to 80% of the diameter of the well.

Pattern Description: Greater than or equal to 1 millimeter and less than or equal to 6 millimeters or Null.

Programmatic Pattern: (RangeP[1*Millimeter, 6*Millimeter] | Automatic) | Null

SamplingDimension

Specifies the size of the grid used for Matrix sampling. For example SamplingDimension->5 will scan a 5 x 5 grid.

Default Value: Automatic

Default Calculation: If the SamplingPattern is set to Matrix, SamplingDimension will be set to 3.

Pattern Description: Greater than or equal to 2 and less than or equal to 30 or Null.

Programmatic Pattern: (RangeP[2, 30] | Automatic) | Null

Post Experiment

SamplesInStorageCondition

The non-default conditions under which the SamplesIn of this experiment should be stored after the protocol is completed. If left unset, SamplesIn will be stored according to their current StorageCondition.

Default Value: Null

Pattern Description: {AmbientStorage, Refrigerator, Freezer, DeepFreezer, CryogenicStorage, YeastIncubation, BacteriaIncubation, MammalianIncubation, TissueCultureCellsIncubation, MicrobialCellsIncubation, MicrobialCellsShakingIncubation, YeastCellsIncubation, YeastCellsShakingIncubation, ViralIncubation, AcceleratedTesting, IntermediateTesting, LongTermTesting, UVVisLightTesting} or Disposal or Null.

Programmatic Pattern: (Alternatives[SampleStorageTypeP | Disposal]) | Null

Index Matches to: experiment samples



Sample Prep Options

Sample Preparation

PreparatoryUnitOperations

Specifies a sequence of transferring, aliquoting, consolidating, or mixing of new or existing samples before the main experiment. These prepared samples can be used in the main experiment by referencing their defined name. For more information, please reference the documentation for ExperimentSampleManipulation.

Default Value: Null

Pattern Description: List of one or more unit Operation ManualSamplePreparation or RoboticSamplePreparation or unit Operation must match SamplePreparationP entries or Null.

Programmatic Pattern: {((ManualSamplePreparationMethodP | RoboticSamplePreparationMethodP) | SamplePreparationP)..} | Null

PreparatoryPrimitives

Specifies a sequence of transferring, aliquoting, consolidating, or mixing of new or existing samples before the main experiment. These prepared samples can be used in the main experiment by referencing their defined name. For more information, please reference the documentation for ExperimentSampleManipulation.

Default Value: Null

Pattern Description: List of one or more a primitive with head Define, Transfer, Mix, Aliquot, Consolidation, FillToVolume, Incubate, Filter, Wait, Centrifuge, or Resuspend entries or Null.

Programmatic Pattern: {SampleManipulationP..} | Null

Preparatory Incubation

Incubate

Indicates if the SamplesIn should be incubated at a fixed temperature prior to starting the experiment or any aliquoting. Sample Preparation occurs in the order of Incubation, Centrifugation, Filtration, and then Aliquoting (if specified).

Default Value: Automatic

Default Calculation: Resolves to True if any of the corresponding Incubation options are set. Otherwise, resolves to False.

Pattern Description: True or False.

Programmatic Pattern: BooleanP | Automatic

Index Matches to: experiment samples

IncubationTemperature

Temperature at which the SamplesIn should be incubated for the duration of the IncubationTime prior to starting the experiment.

Default Value: Automatic

Pattern Description: Ambient or greater than or equal to -20 degrees Celsius and less than or equal to 500 degrees Celsius or Null.

Programmatic Pattern: ((Ambient | RangeP[$MinIncubationTemperature, $MaxIncubationTemperature]) | Automatic) | Null

Index Matches to: experiment samples

IncubationTime

Duration for which SamplesIn should be incubated at the IncubationTemperature, prior to starting the experiment.

Default Value: Automatic

Pattern Description: Greater than or equal to 1 minute and less than or equal to 72 hours or Null.

Programmatic Pattern: (RangeP[1*Minute, $MaxExperimentTime] | Automatic) | Null

Index Matches to: experiment samples

Mix

Indicates if this sample should be mixed while incubated, prior to starting the experiment.

Default Value: Automatic

Default Calculation: Automatically resolves to True if any Mix related options are set. Otherwise, resolves to False.

Pattern Description: True or False or Null.

Programmatic Pattern: (BooleanP | Automatic) | Null

Index Matches to: experiment samples

MixType

Indicates the style of motion used to mix the sample, prior to starting the experiment.

Default Value: Automatic

Default Calculation: Automatically resolves based on the container of the sample and the Mix option.

Pattern Description: Roll, Vortex, Sonicate, Pipette, Invert, Stir, Shake, Homogenize, Swirl, Disrupt, or Nutate or Null.

Programmatic Pattern: (MixTypeP | Automatic) | Null

Index Matches to: experiment samples

MixUntilDissolved

Indicates if the mix should be continued up to the MaxIncubationTime or MaxNumberOfMixes (chosen according to the mix Type), in an attempt dissolve any solute. Any mixing/incubation will occur prior to starting the experiment.

Default Value: Automatic

Default Calculation: Automatically resolves to True if MaxIncubationTime or MaxNumberOfMixes is set.

Pattern Description: True or False or Null.

Programmatic Pattern: (BooleanP | Automatic) | Null

Index Matches to: experiment samples

MaxIncubationTime

Maximum duration of time for which the samples will be mixed while incubated in an attempt to dissolve any solute, if the MixUntilDissolved option is chosen. This occurs prior to starting the experiment.

Default Value: Automatic

Default Calculation: Automatically resolves based on MixType, MixUntilDissolved, and the container of the given sample.

Pattern Description: Greater than or equal to 1 minute and less than or equal to 72 hours or Null.

Programmatic Pattern: (RangeP[1*Minute, $MaxExperimentTime] | Automatic) | Null

Index Matches to: experiment samples

IncubationInstrument

The instrument used to perform the Mix and/or Incubation, prior to starting the experiment.

Default Value: Automatic

Default Calculation: Automatically resolves based on the options Mix, Temperature, MixType and container of the sample.

Pattern Description: An object of type or subtype Model[Instrument, Roller], Model[Instrument, OverheadStirrer], Model[Instrument, Vortex], Model[Instrument, Shaker], Model[Instrument, BottleRoller], Model[Instrument, Roller], Model[Instrument, Sonicator], Model[Instrument, HeatBlock], Model[Instrument, Homogenizer], Model[Instrument, Disruptor], Model[Instrument, Nutator], Model[Instrument, Thermocycler], Model[Instrument, EnvironmentalChamber], Model[Instrument, Pipette], Object[Instrument, Roller], Object[Instrument, OverheadStirrer], Object[Instrument, Vortex], Object[Instrument, Shaker], Object[Instrument, BottleRoller], Object[Instrument, Roller], Object[Instrument, Sonicator], Object[Instrument, HeatBlock], Object[Instrument, Homogenizer], Object[Instrument, Disruptor], Object[Instrument, Nutator], Object[Instrument, Thermocycler], Object[Instrument, EnvironmentalChamber], or Object[Instrument, Pipette] or Null.

Programmatic Pattern: (ObjectP[Join[MixInstrumentModels, MixInstrumentObjects]] | Automatic) | Null

Index Matches to: experiment samples

AnnealingTime

Minimum duration for which the SamplesIn should remain in the incubator allowing the system to settle to room temperature after the IncubationTime has passed but prior to starting the experiment.

Default Value: Automatic

Pattern Description: Greater than or equal to 0 minutes and less than or equal to 72 hours or Null.

Programmatic Pattern: (RangeP[0*Minute, $MaxExperimentTime] | Automatic) | Null

Index Matches to: experiment samples

IncubateAliquotContainer

The desired type of container that should be used to prepare and house the incubation samples which should be used in lieu of the SamplesIn for the experiment.

Default Value: Automatic

Pattern Description: An object of type or subtype Model[Container] or {Index, Container} or Null.

Programmatic Pattern: ((ObjectP[Model[Container]] | {GreaterEqualP[1, 1] | (Automatic | Null), (ObjectP[{Model[Container], Object[Container]}] | _String) | Automatic}) | Automatic) | Null

Index Matches to: experiment samples

IncubateAliquotDestinationWell

The desired position in the corresponding IncubateAliquotContainer in which the aliquot samples will be placed.

Default Value: Automatic

Default Calculation: Automatically resolves to A1 in containers with only one position. For plates, fills wells in the order provided by the function AllWells.

Pattern Description: Any well from A1 to H12 or Null.

Programmatic Pattern: (WellPositionP | Automatic) | Null

Index Matches to: experiment samples

IncubateAliquot

The amount of each sample that should be transferred from the SamplesIn into the IncubateAliquotContainer when performing an aliquot before incubation.

Default Value: Automatic

Default Calculation: Automatically set as the smaller between the current sample volume and the maximum volume of the destination container.

Pattern Description: All or greater than or equal to 1 microliter and less than or equal to 20 liters or Null.

Programmatic Pattern: ((RangeP[1*Microliter, 20*Liter] | All) | Automatic) | Null

Index Matches to: experiment samples

Preparatory Centrifugation

Centrifuge

Indicates if the SamplesIn should be centrifuged prior to starting the experiment or any aliquoting. Sample Preparation occurs in the order of Incubation, Centrifugation, Filtration, and then Aliquoting (if specified).

Default Value: Automatic

Default Calculation: Resolves to True if any of the corresponding Centrifuge options are set. Otherwise, resolves to False.

Pattern Description: True or False.

Programmatic Pattern: BooleanP | Automatic

Index Matches to: experiment samples

CentrifugeInstrument

The centrifuge that will be used to spin the provided samples prior to starting the experiment.

Default Value: Automatic

Pattern Description: An object of type or subtype Model[Instrument, Centrifuge] or Object[Instrument, Centrifuge] or Null.

Programmatic Pattern: (ObjectP[{Model[Instrument, Centrifuge], Object[Instrument, Centrifuge]}] | Automatic) | Null

Index Matches to: experiment samples

CentrifugeIntensity

The rotational speed or the force that will be applied to the samples by centrifugation prior to starting the experiment.

Default Value: Automatic

Pattern Description: Greater than 0 revolutions per minute or greater than 0 standard accelerations due to gravity on the surface of the earth or Null.

Programmatic Pattern: ((GreaterP[0*RPM] | GreaterP[0*GravitationalAcceleration]) | Automatic) | Null

Index Matches to: experiment samples

CentrifugeTime

The amount of time for which the SamplesIn should be centrifuged prior to starting the experiment.

Default Value: Automatic

Pattern Description: Greater than 0 minutes or Null.

Programmatic Pattern: (GreaterP[0*Minute] | Automatic) | Null

Index Matches to: experiment samples

CentrifugeTemperature

The temperature at which the centrifuge chamber should be held while the samples are being centrifuged prior to starting the experiment.

Default Value: Automatic

Pattern Description: Ambient or greater than or equal to -10 degrees Celsius and less than or equal to 40 degrees Celsius or Null.

Programmatic Pattern: ((Ambient | RangeP[-10*Celsius, 40*Celsius]) | Automatic) | Null

Index Matches to: experiment samples

CentrifugeAliquotContainer

The desired type of container that should be used to prepare and house the centrifuge samples which should be used in lieu of the SamplesIn for the experiment.

Default Value: Automatic

Pattern Description: An object of type or subtype Model[Container] or {Index, Container} or Null.

Programmatic Pattern: ((ObjectP[Model[Container]] | {GreaterEqualP[1, 1] | (Automatic | Null), (ObjectP[{Model[Container], Object[Container]}] | _String) | Automatic}) | Automatic) | Null

Index Matches to: experiment samples

CentrifugeAliquotDestinationWell

The desired position in the corresponding AliquotContainer in which the aliquot samples will be placed.

Default Value: Automatic

Default Calculation: Automatically resolves to A1 in containers with only one position. For plates, fills wells in the order provided by the function AllWells.

Pattern Description: Any well from A1 to H12 or Null.

Programmatic Pattern: (WellPositionP | Automatic) | Null

Index Matches to: experiment samples

CentrifugeAliquot

The amount of each sample that should be transferred from the SamplesIn into the CentrifugeAliquotContainer when performing an aliquot before centrifugation.

Default Value: Automatic

Default Calculation: Automatically set as the smaller between the current sample volume and the maximum volume of the destination container.

Pattern Description: All or greater than or equal to 1 microliter and less than or equal to 20 liters or Null.

Programmatic Pattern: ((RangeP[1*Microliter, 20*Liter] | All) | Automatic) | Null

Index Matches to: experiment samples

Preparatory Filtering

Filtration

Indicates if the SamplesIn should be filter prior to starting the experiment or any aliquoting. Sample Preparation occurs in the order of Incubation, Centrifugation, Filtration, and then Aliquoting (if specified).

Default Value: Automatic

Default Calculation: Resolves to True if any of the corresponding Filter options are set. Otherwise, resolves to False.

Pattern Description: True or False.

Programmatic Pattern: BooleanP | Automatic

Index Matches to: experiment samples

FiltrationType

The type of filtration method that should be used to perform the filtration.

Default Value: Automatic

Default Calculation: Will automatically resolve to a filtration type appropriate for the volume of sample being filtered.

Pattern Description: PeristalticPump, Centrifuge, Vacuum, Syringe, or AirPressure or Null.

Programmatic Pattern: (FiltrationTypeP | Automatic) | Null

Index Matches to: experiment samples

FilterInstrument

The instrument that should be used to perform the filtration.

Default Value: Automatic

Default Calculation: Will automatically resolved to an instrument appropriate for the filtration type.

Pattern Description: An object of type or subtype Model[Instrument, FilterBlock], Object[Instrument, FilterBlock], Model[Instrument, PeristalticPump], Object[Instrument, PeristalticPump], Model[Instrument, VacuumPump], Object[Instrument, VacuumPump], Model[Instrument, Centrifuge], Object[Instrument, Centrifuge], Model[Instrument, SyringePump], or Object[Instrument, SyringePump] or Null.

Programmatic Pattern: (ObjectP[{Model[Instrument, FilterBlock], Object[Instrument, FilterBlock], Model[Instrument, PeristalticPump], Object[Instrument, PeristalticPump], Model[Instrument, VacuumPump], Object[Instrument, VacuumPump], Model[Instrument, Centrifuge], Object[Instrument, Centrifuge], Model[Instrument, SyringePump], Object[Instrument, SyringePump]}] | Automatic) | Null

Index Matches to: experiment samples

Filter

The filter that should be used to remove impurities from the SamplesIn prior to starting the experiment.

Default Value: Automatic

Default Calculation: Will automatically resolve to a filter appropriate for the filtration type and instrument.

Pattern Description: An object of type or subtype Model[Container, Plate, Filter], Model[Container, Vessel, Filter], or Model[Item, Filter] or Null.

Programmatic Pattern: (ObjectP[{Model[Container, Plate, Filter], Model[Container, Vessel, Filter], Model[Item, Filter]}] | Automatic) | Null

Index Matches to: experiment samples

FilterMaterial

The membrane material of the filter that should be used to remove impurities from the SamplesIn prior to starting the experiment.

Default Value: Automatic

Default Calculation: Resolves to an appropriate filter material for the given sample is Filtration is set to True.

Pattern Description: Cellulose, Cotton, Polyethylene, PTFE, Nylon, PES, PLUS, PVDF, GlassFiber, GHP, UHMWPE, EPDM, DuraporePVDF, GxF, ZebaDesaltingResin, NickelResin, Silica, or HLB or Null.

Programmatic Pattern: (FilterMembraneMaterialP | Automatic) | Null

Index Matches to: experiment samples

PrefilterMaterial

The material from which the prefilter filtration membrane should be made of to remove impurities from the SamplesIn prior to starting the experiment.

Default Value: Automatic

Default Calculation: By default, no prefiltration is performed on samples, even when Filter->True.

Pattern Description: Cellulose, Cotton, Polyethylene, PTFE, Nylon, PES, PLUS, PVDF, GlassFiber, GHP, UHMWPE, EPDM, DuraporePVDF, GxF, ZebaDesaltingResin, NickelResin, Silica, or HLB or Null.

Programmatic Pattern: (FilterMembraneMaterialP | Automatic) | Null

Index Matches to: experiment samples

FilterPoreSize

The pore size of the filter that should be used when removing impurities from the SamplesIn prior to starting the experiment.

Default Value: Automatic

Default Calculation: Resolves to an appropriate filter pore size for the given sample is Filtration is set to True.

Pattern Description: 0.008 micrometers, 0.1 micrometers, 0.22 micrometers, 0.45 micrometers, 1. micrometer, 1.1 micrometers, 2.5 micrometers, 6. micrometers, 20. micrometers, 30. micrometers, or 100. micrometers or Null.

Programmatic Pattern: (FilterSizeP | Automatic) | Null

Index Matches to: experiment samples

PrefilterPoreSize

The pore size of the filter; all particles larger than this should be removed during the filtration.

Default Value: Automatic

Default Calculation: By default, no prefiltration is performed on samples, even when Filter->True.

Pattern Description: 0.008 micrometers, 0.1 micrometers, 0.22 micrometers, 0.45 micrometers, 1. micrometer, 1.1 micrometers, 2.5 micrometers, 6. micrometers, 20. micrometers, 30. micrometers, or 100. micrometers or Null.

Programmatic Pattern: (FilterSizeP | Automatic) | Null

Index Matches to: experiment samples

FilterSyringe

The syringe used to force that sample through a filter.

Default Value: Automatic

Default Calculation: Resolves to an syringe appropriate to the volume of sample being filtered, if Filtration is set to True.

Pattern Description: An object of type or subtype Model[Container, Syringe] or Object[Container, Syringe] or a prepared sample or Null.

Programmatic Pattern: ((ObjectP[{Model[Container, Syringe], Object[Container, Syringe]}] | _String) | Automatic) | Null

Index Matches to: experiment samples

FilterHousing

The filter housing that should be used to hold the filter membrane when filtration is performed using a standalone filter membrane.

Default Value: Automatic

Default Calculation: Resolve to an housing capable of holding the size of the membrane being used, if filter with Membrane FilterType is being used and Filtration is set to True.

Pattern Description: An object of type or subtype Model[Instrument, FilterHousing], Object[Instrument, FilterHousing], Model[Instrument, FilterBlock], or Object[Instrument, FilterBlock] or Null.

Programmatic Pattern: (ObjectP[{Model[Instrument, FilterHousing], Object[Instrument, FilterHousing], Model[Instrument, FilterBlock], Object[Instrument, FilterBlock]}] | Automatic) | Null

Index Matches to: experiment samples

FilterIntensity

The rotational speed or force at which the samples will be centrifuged during filtration.

Default Value: Automatic

Default Calculation: Will automatically resolve to 2000 GravitationalAcceleration if FiltrationType is Centrifuge and Filtration is True.

Pattern Description: Greater than 0 revolutions per minute or greater than 0 standard accelerations due to gravity on the surface of the earth or Null.

Programmatic Pattern: ((GreaterP[0*RPM] | GreaterP[0*GravitationalAcceleration]) | Automatic) | Null

Index Matches to: experiment samples

FilterTime

The amount of time for which the samples will be centrifuged during filtration.

Default Value: Automatic

Default Calculation: Will automatically resolve to 5 Minute if FiltrationType is Centrifuge and Filtration is True.

Pattern Description: Greater than 0 minutes or Null.

Programmatic Pattern: (GreaterP[0*Minute] | Automatic) | Null

Index Matches to: experiment samples

FilterTemperature

The temperature at which the centrifuge chamber will be held while the samples are being centrifuged during filtration.

Default Value: Automatic

Default Calculation: Will automatically resolve to 22 Celsius if FiltrationType is Centrifuge and Filtration is True.

Pattern Description: Greater than or equal to 4 degrees Celsius or Null.

Programmatic Pattern: ((Alternatives[GreaterEqualP[4*Celsius]]) | Automatic) | Null

Index Matches to: experiment samples

FilterContainerOut

The desired container filtered samples should be produced in or transferred into by the end of filtration, with indices indicating grouping of samples in the same plates, if desired.

Default Value: Automatic

Default Calculation: Automatically set as the PreferredContainer for the Volume of the sample. For plates, attempts to fill all wells of a single plate with the same model before using another one.

Pattern Description: An object of type or subtype Model[Container] or Object[Container] or a prepared sample or {Index, Container} or Null.

Programmatic Pattern: (((ObjectP[{Model[Container], Object[Container]}] | _String) | {GreaterEqualP[1, 1] | Automatic, (ObjectP[{Model[Container], Object[Container]}] | _String) | Automatic}) | Automatic) | Null

Index Matches to: experiment samples

FilterAliquotDestinationWell

The desired position in the corresponding AliquotContainer in which the aliquot samples will be placed.

Default Value: Automatic

Default Calculation: Automatically resolves to A1 in containers with only one position. For plates, fills wells in the order provided by the function AllWells.

Pattern Description: Any well from A1 to H12 or Null.

Programmatic Pattern: (WellPositionP | Automatic) | Null

Index Matches to: experiment samples

FilterAliquotContainer

The desired type of container that should be used to prepare and house the filter samples which should be used in lieu of the SamplesIn for the experiment.

Default Value: Automatic

Pattern Description: An object of type or subtype Model[Container] or {Index, Container} or Null.

Programmatic Pattern: ((ObjectP[Model[Container]] | {GreaterEqualP[1, 1] | (Automatic | Null), (ObjectP[{Model[Container], Object[Container]}] | _String) | Automatic}) | Automatic) | Null

Index Matches to: experiment samples

FilterAliquot

The amount of each sample that should be transferred from the SamplesIn into the FilterAliquotContainer when performing an aliquot before filtration.

Default Value: Automatic

Default Calculation: Automatically set as the smaller between the current sample volume and the maximum volume of the destination container.

Pattern Description: All or greater than or equal to 1 microliter and less than or equal to 20 liters or Null.

Programmatic Pattern: ((RangeP[1*Microliter, 20*Liter] | All) | Automatic) | Null

Index Matches to: experiment samples

FilterSterile

Indicates if the filtration of the samples should be done in a sterile environment.

Default Value: Automatic

Default Calculation: Resolve to False if Filtration is indicated. If sterile filtration is desired, this option must manually be set to True.

Pattern Description: True or False or Null.

Programmatic Pattern: (BooleanP | Automatic) | Null

Index Matches to: experiment samples

Aliquoting

Aliquot

Indicates if aliquots should be taken from the SamplesIn and transferred into new AliquotSamples used in lieu of the SamplesIn for the experiment. Note that if NumberOfReplicates is specified this indicates that the input samples will also be aliquoted that number of times. Note that Aliquoting (if specified) occurs after any Sample Preparation (if specified).

Default Value: Automatic

Pattern Description: True or False.

Programmatic Pattern: BooleanP | Automatic

Index Matches to: experiment samples

AliquotAmount

The amount of a sample that should be transferred from the input samples into aliquots.

Default Value: Automatic

Default Calculation: Automatically set as the smaller between the current sample volume and the maximum volume of the destination container if a liquid, or the current Mass or Count if a solid or counted item, respectively.

Pattern Description: All or Count or Count or Mass or Volume or Null.

Programmatic Pattern: ((RangeP[1*Microliter, 20*Liter] | RangeP[1*Milligram, 20*Kilogram] | GreaterP[0*Unit, 1*Unit] | GreaterP[0., 1.] | All) | Automatic) | Null

Index Matches to: experiment samples

TargetConcentration

The desired final concentration of analyte in the AliquotSamples after dilution of aliquots of SamplesIn with the ConcentratedBuffer and BufferDiluent which should be used in lieu of the SamplesIn for the experiment.

Default Value: Automatic

Default Calculation: Automatically calculated based on aliquot and buffer volumes.

Pattern Description: Greater than 0 molar or greater than 0 grams per liter or Null.

Programmatic Pattern: ((GreaterP[0*Molar] | GreaterP[0*(Gram/Liter)]) | Automatic) | Null

Index Matches to: experiment samples

TargetConcentrationAnalyte

The substance whose final concentration is attained with the TargetConcentration option.

Default Value: Automatic

Default Calculation: Automatically set to the first value in the Analytes field of the input sample, or, if not populated, to the first analyte in the Composition field of the input sample, or if none exist, the first identity model of any kind in the Composition field.

Pattern Description: An object of type or subtype Model[Molecule], Model[Molecule, cDNA], Model[Molecule, Oligomer], Model[Molecule, Transcript], Model[Molecule, Protein], Model[Molecule, Protein, Antibody], Model[Molecule, Carbohydrate], Model[Molecule, Polymer], Model[Resin], Model[Resin, SolidPhaseSupport], Model[Lysate], Model[ProprietaryFormulation], Model[Virus], Model[Cell], Model[Cell, Mammalian], Model[Cell, Bacteria], Model[Cell, Yeast], Model[Tissue], Model[Material], or Model[Species] or Null.

Programmatic Pattern: (ObjectP[IdentityModelTypes] | Automatic) | Null

Index Matches to: experiment samples

AssayVolume

The desired total volume of the aliquoted sample plus dilution buffer.

Default Value: Automatic

Default Calculation: Automatically determined based on Volume and TargetConcentration option values.

Pattern Description: Greater than or equal to 1 microliter and less than or equal to 20 liters or Null.

Programmatic Pattern: (RangeP[1*Microliter, 20*Liter] | Automatic) | Null

Index Matches to: experiment samples

ConcentratedBuffer

The concentrated buffer which should be diluted by the BufferDilutionFactor in the final solution (i.e., the combination of the sample, ConcentratedBuffer, and BufferDiluent). The ConcentratedBuffer and BufferDiluent will be combined and then mixed with the sample, where the combined volume of these buffers is the difference between the AliquotAmount and the total AssayVolume.

Default Value: Automatic

Pattern Description: An object of type or subtype Model[Sample] or Object[Sample] or a prepared sample or Null.

Programmatic Pattern: ((ObjectP[{Model[Sample], Object[Sample]}] | _String) | Automatic) | Null

Index Matches to: experiment samples

BufferDilutionFactor

The dilution factor by which the concentrated buffer should be diluted in the final solution (i.e., the combination of the sample, ConcentratedBuffer, and BufferDiluent). The ConcentratedBuffer and BufferDiluent will be combined and then mixed with the sample, where the combined volume of these buffers is the difference between the AliquotAmount and the total AssayVolume.

Default Value: Automatic

Default Calculation: If ConcentratedBuffer is specified, automatically set to the ConcentrationFactor of that sample; otherwise, set to Null.

Pattern Description: Greater than or equal to 1 or Null.

Programmatic Pattern: (GreaterEqualP[1] | Automatic) | Null

Index Matches to: experiment samples

BufferDiluent

The buffer used to dilute the aliquot sample such that ConcentratedBuffer is diluted by BufferDilutionFactor in the final solution. The ConcentratedBuffer and BufferDiluent will be combined and then mixed with the sample, where the combined volume of these buffers is the difference between the AliquotAmount and the total AssayVolume.

Default Value: Automatic

Default Calculation: Automatically resolves to Model[Sample, "Milli-Q water"] if ConcentratedBuffer is specified; otherwise, resolves to Null.

Pattern Description: An object of type or subtype Model[Sample] or Object[Sample] or a prepared sample or Null.

Programmatic Pattern: ((ObjectP[{Model[Sample], Object[Sample]}] | _String) | Automatic) | Null

Index Matches to: experiment samples

AssayBuffer

The buffer that should be added to any aliquots requiring dilution, where the volume of this buffer added is the difference between the AliquotAmount and the total AssayVolume.

Default Value: Automatic

Default Calculation: Automatically resolves to Model[Sample, "Milli-Q water"] if ConcentratedBuffer is not specified; otherwise, resolves to Null.

Pattern Description: An object of type or subtype Model[Sample] or Object[Sample] or a prepared sample or Null.

Programmatic Pattern: ((ObjectP[{Model[Sample], Object[Sample]}] | _String) | Automatic) | Null

Index Matches to: experiment samples

AliquotSampleStorageCondition

The non-default conditions under which any aliquot samples generated by this experiment should be stored after the protocol is completed.

Default Value: Automatic

Pattern Description: {AmbientStorage, Refrigerator, Freezer, DeepFreezer, CryogenicStorage, YeastIncubation, BacteriaIncubation, MammalianIncubation, TissueCultureCellsIncubation, MicrobialCellsIncubation, MicrobialCellsShakingIncubation, YeastCellsIncubation, YeastCellsShakingIncubation, ViralIncubation, AcceleratedTesting, IntermediateTesting, LongTermTesting, UVVisLightTesting} or Disposal or Null.

Programmatic Pattern: ((SampleStorageTypeP | Disposal) | Automatic) | Null

Index Matches to: experiment samples

DestinationWell

The desired position in the corresponding AliquotContainer in which the aliquot samples will be placed.

Default Value: Automatic

Default Calculation: Automatically resolves to A1 in containers with only one position. For plates, fills wells in the order provided by the function AllWells.

Pattern Description: Any well from A1 to H12 or list of one or more any well from A1 to H12 or any well from A1 to H12 entries or Null.

Programmatic Pattern: ((WellPositionP | {((Automatic | Null) | WellPositionP)..}) | Automatic) | Null

AliquotContainer

The desired type of container that should be used to prepare and house the aliquot samples, with indices indicating grouping of samples in the same plates, if desired. This option will resolve to be the length of the SamplesIn * NumberOfReplicates.

Default Value: Automatic

Default Calculation: Automatically set as the PreferredContainer for the AssayVolume of the sample. For plates, attempts to fill all wells of a single plate with the same model before aliquoting into the next.

Pattern Description: An object of type or subtype Model[Container] or Object[Container] or a prepared sample or Automatic or Null or {Index, Container} or list of one or more an object of type or subtype Model[Container] or Object[Container] or a prepared sample or Automatic or Null entries or list of one or more Automatic or Null or {Index, Container} entries or Null.

Programmatic Pattern: (((ObjectP[{Model[Container], Object[Container]}] | _String) | (Automatic | Null) | {GreaterEqualP[1, 1] | (Automatic | Null), (ObjectP[{Model[Container], Object[Container]}] | _String) | (Automatic | Null)} | {((ObjectP[{Model[Container], Object[Container]}] | _String) | (Automatic | Null))..} | {({GreaterEqualP[1, 1] | (Automatic | Null), (ObjectP[{Model[Container], Object[Container]}] | _String) | (Automatic | Null)} | (Automatic | Null))..}) | Automatic) | Null

AliquotPreparation

Indicates the desired scale at which liquid handling used to generate aliquots will occur.

Default Value: Automatic

Default Calculation: Automatic resolution will occur based on manipulation volumes and container types.

Pattern Description: Manual or Robotic or Null.

Programmatic Pattern: (PreparationMethodP | Automatic) | Null

ConsolidateAliquots

Indicates if identical aliquots should be prepared in the same container/position.

Default Value: Automatic

Pattern Description: False or Null.

Programmatic Pattern: (False | Automatic) | Null



Protocol Options

Organizational Information

Template

A template protocol whose methodology should be reproduced in running this experiment. Option values will be inherited from the template protocol, but can be individually overridden by directly specifying values for those options to this Experiment function.

Default Value: Null

Pattern Description: An object of type or subtype Object[Protocol] or an object of type or subtype of Object[Protocol] with UnresolvedOptions, ResolvedOptions specified or Null.

Programmatic Pattern: (ObjectP[Object[Protocol]] | FieldReferenceP[Object[Protocol], {UnresolvedOptions, ResolvedOptions}]) | Null

Name

A object name which should be used to refer to the output object in lieu of an automatically generated ID number.

Default Value: Null

Pattern Description: A string or Null.

Programmatic Pattern: _String | Null

Post Experiment

MeasureWeight

Indicates if any solid samples that are modified in the course of the experiment should have their weights measured and updated after running the experiment. Please note that public samples are weighed regardless of the value of this option.

Default Value: Automatic

Pattern Description: True or False or Null.

Programmatic Pattern: (BooleanP | Automatic) | Null

MeasureVolume

Indicates if any liquid samples that are modified in the course of the experiment should have their volumes measured and updated after running the experiment. Please note that public samples are volume measured regardless of the value of this option.

Default Value: Automatic

Pattern Description: True or False or Null.

Programmatic Pattern: (BooleanP | Automatic) | Null

ImageSample

Indicates if any samples that are modified in the course of the experiment should be freshly imaged after running the experiment. Please note that public samples are imaged regardless of the value of this option.

Default Value: Automatic

Pattern Description: True or False or Null.

Programmatic Pattern: (BooleanP | Automatic) | Null



Example Calls

Excitation and Emission Wavelengths

Select a single excitation wavelength to excite the sample and one wavelength at which emitted light should be read:

ExperimentFluorescencePolarization[mySamples,

 	ExcitationWavelength -> (485 * Nanometer),

 	EmissionWavelength -> (520 * Nanometer)

 ]

Plate Reader Mixing

The assay plate can be mixed during readings by specifying any of the PlateReaderMix options:

ExperimentFluorescencePolarization[mySamples,

 	PlateReaderMix -> True,

 	PlateReaderMixTime -> (1 * Minute),

 	PlateReaderMixRate -> (700 * RPM)

 ]

Gain Setting

Gain can be set as a percentage of the maximum signal the reader can record:

ExperimentFluorescencePolarization[mySamples,

 PrimaryGain -> (50 * Percent)]

Alternatively directly specify the voltage to apply to the PMT. This is generally more helpful in repeat experiments. The gain can be taken from Object[Data, FluorescencePolarization][Gains]

ExperimentFluorescencePolarization[mySamples,

 PrimaryGain -> (2500 * Microvolt)]



Preferred Input Containers

The plate readers can read standard SBS shallow well plates.

The plate readers can inject samples from samples from 2mL, 15mL and 50 mL tubes while recording kinetic signal.



Possible Issues

Evaporation

During long runs evaporation can cause signal drift over time. Additionally using a high NumberOfReadings can lead to an initial hump while the PMT heats up.

Slow Injections

If the injection speed is not sufficient mixing may be inadequate.

Variable Detection Interval

The detection interval is determined by the instrument at run time. It depends on the number of wells being read, mixing parameters, the number of multichromatics, and the NumberOfReadings.

[end context 1]

Here are summaries of the previous meetings:

[begin summary 1]

### Revised Agenda Response

In response to the Scientific Critic's feedback, I have further refined our approach to ensure a comprehensive and detailed plan for our drug discovery project using machine learning.

### Answers

1. **What is the specific drug modality that you are proposing?**

   **Answer**: Peptide-based therapeutics.

   **Justification**: Peptide-based therapeutics are chosen due to their compatibility with ECL's capabilities, allowing for efficient synthesis and validation. Peptides offer specificity in targeting protein-protein interactions, which aligns with our goal of applying machine learning to optimize sequence design and target interactions. We will employ machine learning techniques such as sequence optimization algorithms and structure prediction models (e.g., AlphaFold) to enhance peptide design. The integration will involve a structured feedback loop where computational predictions are iteratively validated and refined through experimental data from ECL. Success will be measured by improvements in binding affinity, structural stability, and bioavailability, with each iteration aiming to enhance these metrics.

2. **What specific disease/target pairs are you proposing to treat with your choice of drug modality (list five)?**

   **Answer**: 
   1. Type 2 Diabetes - GLP-1 Receptor
   2. Cancer - PD-1/PD-L1
   3. Alzheimer's Disease - Amyloid-beta
   4. Antimicrobial Resistance - MurA/B
   5. Cardiovascular Diseases - PCSK9

   **Justification**: These targets are chosen for their clinical relevance and the availability of robust datasets, which are critical for machine learning applications. Peptides are particularly suitable for these targets due to their ability to modulate protein interactions with high specificity. For instance, GLP-1 receptor agonists have shown promise in diabetes management, and PD-1/PD-L1 inhibitors are pivotal in cancer immunotherapy. Peptides can address the challenges of specificity and delivery in these contexts, offering unique therapeutic insights. Expected outcomes include improved binding affinity and stability of peptides, which will be validated through assays such as HPLC and LCMS at ECL. Potential risks, such as off-target effects and peptide degradation, will be mitigated through careful design and chemical modifications.

3. **Why are these diseases and targets appropriate for your choice of drug modality?**

   **Answer**: These diseases present high unmet medical needs and involve targets that can be effectively modulated by peptides. The availability of existing data supports model training, and ECL can facilitate rapid empirical validation. Peptides offer advantages in specificity, and the selected targets allow for the integration of machine learning with experimental validation within the given timeframe. For example, peptides targeting amyloid-beta in Alzheimer's can potentially disrupt plaque formation, while those targeting MurA/B can inhibit bacterial cell wall synthesis, addressing antimicrobial resistance. Preliminary studies and literature support the feasibility of peptide interventions for these targets, providing a strong foundation for our approach. Specific challenges, such as peptide solubility and stability, will be addressed through chemical modifications and formulation strategies.

### Next Steps

1. **Data Collection and Preparation**: Begin by collecting and preprocessing data from relevant databases such as PDB, BindingDB, and UniProt to train machine learning models focusing on peptide interactions with selected targets. Ensure data quality and relevance through rigorous auditing.

2. **Model Development and Validation**: Develop interpretable machine learning models using sequence-based and structure-based approaches. Employ frameworks like TensorFlow and PyTorch for model development, incorporating techniques such as attention mechanisms and feature importance metrics. Validate models through iterative feedback loops with experimental data from ECL. Evaluation criteria will include binding affinity predictions, structural stability, and experimental validation outcomes.

3. **Pilot Studies at ECL**: Conduct pilot studies to empirically validate key peptide modifications like cyclization, focusing on the most promising targets. Use these studies to inform model refinement and enhance prediction accuracy. Criteria for target selection will include clinical relevance, data availability, and preliminary computational predictions. Potential challenges, such as peptide solubility and stability, will be addressed through chemical modifications and formulation strategies.

4. **Phased Implementation**: Implement a phased approach to focus initially on one or two high-priority targets to ensure feasibility within the timeline. Iterate based on learnings and expand to additional targets as data and insights accumulate.

5. **Regular Review and Adaptation**: Schedule regular team meetings to review progress, discuss results, and adapt the project plan based on emerging data and insights. Ensure all team members are aligned on objectives and timelines, maintaining thorough documentation and transparent communication.

By incorporating these detailed steps and justifications, we aim to achieve a project that maximizes both scientific impact and clinical relevance, leveraging machine learning and ECL's capabilities effectively within our constraints.

[end summary 1]

[begin summary 2]

### Revised Agenda Response

Our project aims to leverage machine learning for drug discovery, focusing on peptide-based therapeutics. The objectives are to ensure high clinical value, demonstrate a significant application of machine learning, and utilize Emerald Cloud Labs (ECL) for all experimental validation within a 3-month timeframe. Below is the refined experimental workflow for synthesizing and validating peptides, incorporating detailed feedback and improvements.

### Answers

1. **What experiments in order will you run to synthesize the peptides in preparation for validation?**

   **Answer**: 
   - **ExperimentPeptideSynthesis**
   - **ExperimentSolidPhaseExtraction**
   - **ExperimentHPLC**
   - **ExperimentMassSpectrometry**

   **Justification**: This sequence ensures efficient synthesis and purification. **ExperimentPeptideSynthesis** constructs the peptide sequences based on machine learning predictions using algorithms like neural networks and support vector machines to optimize sequence selection for target binding and stability. **ExperimentSolidPhaseExtraction** targets specific impurities like unreacted reagents and by-products. **ExperimentHPLC** further purifies peptides, ensuring they meet a purity threshold of >95%, determined based on historical data and computational predictions. **ExperimentMassSpectrometry** confirms molecular identity and purity, with a focus on achieving a mass accuracy within 0.1 Da of the predicted value.

2. **What is the role of each experiment in the synthesis workflow?**

   **Answer**: 
   - **ExperimentPeptideSynthesis**: Constructs peptide sequences using solid-phase synthesis, guided by computational predictions to optimize sequence selection for target binding and stability. Algorithms such as neural networks and support vector machines are used to predict sequence stability and binding affinity.
   - **ExperimentSolidPhaseExtraction**: Removes impurities such as unreacted reagents and by-products, ensuring initial purification.
   - **ExperimentHPLC**: Provides high-resolution purification, confirming that peptides meet the >95% purity threshold necessary for validation, a criterion based on historical data and computational predictions.
   - **ExperimentMassSpectrometry**: Confirms molecular identity and purity, ensuring mass accuracy within 0.1 Da of predicted values.

   **Justification**: Each experiment is critical for ensuring high-quality peptide synthesis, with specific criteria for success that align with machine learning predictions.

3. **What experiments will you perform to validate the synthesized peptides?**

   **Answer**: 
   - **ExperimentLCMS**
   - **ExperimentCircularDichroism**
   - **ExperimentBioLayerInterferometry**
   - **ExperimentThermalShift**

   **Justification**: This set of experiments provides comprehensive validation. **ExperimentLCMS** confirms mass and purity post-synthesis. **ExperimentCircularDichroism** assesses secondary structure and folding, ensuring structural integrity. **ExperimentBioLayerInterferometry** evaluates binding kinetics and affinities, with a focus on achieving a binding affinity (Kd) of <10 μM, a threshold informed by clinical relevance and computational predictions. **ExperimentThermalShift** tests thermal stability, ensuring a melting temperature (Tm) above 50°C, based on stability requirements for therapeutic efficacy.

4. **What is the role of each experiment in the validation workflow?**

   **Answer**: 
   - **ExperimentLCMS**: Confirms mass and purity, ensuring synthesized peptides match predicted structures.
   - **ExperimentCircularDichroism**: Assesses secondary structure and folding, confirming structural integrity.
   - **ExperimentBioLayerInterferometry**: Evaluates binding kinetics and affinities, focusing on achieving a Kd of <10 μM.
   - **ExperimentThermalShift**: Tests thermal stability, ensuring a Tm above 50°C.

   **Justification**: These roles ensure that peptide candidates meet all necessary criteria for therapeutic efficacy, with specific thresholds guiding decision points.

5. **What is the order in which the validation experiments should be run?**

   **Answer**: 
   - **ExperimentLCMS**
   - **ExperimentCircularDichroism**
   - **ExperimentBioLayerInterferometry**
   - **ExperimentThermalShift**

   **Justification**: This order prioritizes confirming identity and structure before assessing functional properties and stability, effectively filtering candidates with issues at each stage. Results from each experiment inform subsequent steps, ensuring a logical progression. For instance, structural insights from **Circular Dichroism** can refine binding studies in **BioLayer Interferometry**.

6. **What are the decision points for whether to proceed with further validation for each peptide?**

   **Answer**: 
   - **LCMS**: If purity and mass do not meet thresholds (>95% purity, mass accuracy within 0.1 Da), halt further validation.
   - **Circular Dichroism**: Improper folding or instability indicates stopping further validation.
   - **BioLayer Interferometry**: Low binding affinity (Kd >10 μM) suggests revisiting design before proceeding.
   - **Thermal Shift**: Insufficient thermal stability (Tm <50°C) indicates a need for redesign.

   **Justification**: These decision points focus on structural stability and binding efficacy, critical for identifying promising candidates. Quantitative thresholds ensure transparency and reproducibility.

### Additional Improvements

- **Integration with Machine Learning**: Machine learning predictions guide the selection of peptide sequences and modifications, with feedback loops established to refine models based on experimental outcomes. These loops occur bi-weekly, allowing for timely adjustments to computational models and experimental strategies.
- **Risk Management**: Potential risks, such as synthesis delays and data integration issues, are managed through regular interdisciplinary meetings and a centralized data management system. Contingency plans include alternative synthesis routes and data backup protocols.
- **Feedback Loops**: Continuous feedback between experimental results and computational models ensures adaptive refinement of predictions and workflow adjustments. This iterative process enhances model accuracy and experimental efficiency.

By addressing these areas, the workflow is enhanced to maximize scientific and clinical impact, aligning with the agenda's goals of rigorous validation and impactful application of machine learning in drug discovery.

[end summary 2]

Here is the agenda for the meeting:

You are working on a research project to use machine learning for drug discovery. Your goals are the following: (1) the project must have high clinical value, meaning the research contributes to helping patients, (2) the project must include a scientifically impactful application of machine learning to drug discovery, and (3) the project must use Emerald Cloud Labs (ECL) for all experimental validation with a 3-month limit on experiments. Your team previously decided to pursue peptide-based therapeutics. You previously designed experimental protocols for synthesis and validation of peptides that are designed to bind to a given protein drug target. Now you must implement one of these protocols using ECL. Please implement the ExperimentFluorescencePolarization protocol using the appropriate commands and syntax from ECL, writing out the experiment in the form ExperimentFluorescencePolarization[inputs] where you fill in "inputs" with the appropriate inputs. Please refer to the ECL documentation that is provided as context with example function calls and the full set of options for the experiment. In general, leave most options at their default values and therefore do not include them in your experiment function call. Only specify options that must be changed from their default value for your specific experiment. For every option that you specify, please state the default value, the different value you chose, and why you chose that value instead of the default.

Medicinal Chemist, please provide your response to the agenda.

## Medicinal Chemist

To implement the `ExperimentFluorescencePolarization` protocol using ECL, we need to carefully select the options that deviate from their default values to suit our specific experimental needs. Below is the proposed experiment setup, along with the rationale for each specified option:

### Experiment Setup

```plaintext
ExperimentFluorescencePolarization[
  mySamples,
  ExcitationWavelength -> (485 * Nanometer),
  EmissionWavelength -> (520 * Nanometer),
  Gain -> (50 * Percent),
  PlateReaderMix -> True,
  PlateReaderMixTime -> (1 * Minute),
  PlateReaderMixRate -> (700 * RPM),
  Temperature -> (37 * Celsius),
  NumberOfReplicates -> 3
]
```

### Specified Options and Justifications

1. **ExcitationWavelength**
   - **Default Value**: Automatic
   - **Chosen Value**: 485 Nanometers
   - **Justification**: This wavelength is commonly used for fluorescein-based tracers, which are often employed in fluorescence polarization assays. It ensures optimal excitation of the fluorophore used in our experiment.

2. **EmissionWavelength**
   - **Default Value**: Automatic
   - **Chosen Value**: 520 Nanometers
   - **Justification**: This emission wavelength corresponds to the emission peak of fluorescein, ensuring accurate measurement of fluorescence polarization.

3. **Gain**
   - **Default Value**: Automatic (90% if an adjustment sample is provided)
   - **Chosen Value**: 50 Percent
   - **Justification**: Setting the gain to 50% ensures that the signal is within the dynamic range of the detector, preventing saturation and allowing for accurate measurement of polarization changes.

4. **PlateReaderMix**
   - **Default Value**: Automatic
   - **Chosen Value**: True
   - **Justification**: Mixing ensures uniform distribution of samples and reagents, which is crucial for consistent and reliable fluorescence polarization measurements.

5. **PlateReaderMixTime**
   - **Default Value**: Automatic (30 seconds if other mix options are specified)
   - **Chosen Value**: 1 Minute
   - **Justification**: A longer mixing time ensures thorough mixing, especially important for samples with higher viscosity or when precise reagent distribution is critical.

6. **PlateReaderMixRate**
   - **Default Value**: Automatic (700 RPM if other mix options are specified)
   - **Chosen Value**: 700 RPM
   - **Justification**: The maximum mixing rate ensures efficient mixing, reducing the risk of sample settling and improving assay consistency.

7. **Temperature**
   - **Default Value**: Ambient
   - **Chosen Value**: 37 Celsius
   - **Justification**: Conducting the experiment at physiological temperature (37°C) is important for maintaining the biological relevance of the assay, especially when studying protein-ligand interactions.

8. **NumberOfReplicates**
   - **Default Value**: Null
   - **Chosen Value**: 3
   - **Justification**: Performing triplicate measurements increases the reliability of the data by allowing for statistical analysis and reducing the impact of outliers.

By specifying these options, we tailor the `ExperimentFluorescencePolarization` protocol to our specific needs, ensuring accurate and reliable results that align with our research objectives.

## User

Scientific Critic, please critique Medicinal Chemist's most recent answer. In your critique, suggest improvements that directly address the agenda and any agenda questions. Prioritize simple solutions over unnecessarily complex ones, but demand more detail where detail is lacking. Additionally, validate whether the answer strictly adheres to the agenda and any agenda questions and provide corrective feedback if it does not. Only provide feedback; do not implement the answer yourself.

## Scientific Critic

The Medicinal Chemist's response provides a good starting point for implementing the `ExperimentFluorescencePolarization` protocol using ECL. However, there are several areas where improvements and additional details are necessary to ensure the response fully aligns with the agenda and provides a comprehensive plan:

1. **Alignment with Agenda Goals**:
   - The agenda emphasizes the need for high clinical value and impactful application of machine learning. The response should explicitly connect the chosen experimental parameters to these goals. For instance, how does the choice of excitation and emission wavelengths, gain, and temperature contribute to the clinical relevance or the integration with machine learning predictions?

2. **Justification for Default Values**:
   - While the response specifies certain options, it does not address why other options are left at their default values. A brief explanation of why defaults are appropriate for those parameters would strengthen the rationale.

3. **Machine Learning Integration**:
   - The agenda specifies the use of machine learning in drug discovery. The response should include how the fluorescence polarization experiment will integrate with machine learning models, such as using the data to refine peptide design or validate computational predictions.

4. **Experimental Context**:
   - More detail is needed on the experimental context, such as the type of fluorophore used and its relevance to the peptide-based therapeutics being studied. This would provide a clearer understanding of how the experiment fits into the broader research project.

5. **Risk Management and Contingency Plans**:
   - The response lacks a discussion on potential risks and how they will be managed. For example, what steps will be taken if the fluorescence polarization results do not align with predictions? Including contingency plans would demonstrate thorough planning.

6. **Decision Points and Iterative Feedback**:
   - The agenda highlights the importance of decision points and iterative feedback loops. The response should specify how the results of this experiment will inform subsequent steps in the research process and how feedback will be used to refine both experimental and computational approaches.

7. **Clarity and Completeness**:
   - Ensure that all specified options are clearly justified with respect to their impact on the experiment's success. For example, while the choice of temperature is justified, the impact of this choice on the specific peptides or targets should be elaborated.

By addressing these points, the Medicinal Chemist can provide a more detailed and aligned response that fully meets the agenda's requirements and enhances the scientific rigor of the proposed experiment.

## User

Medicinal Chemist, please modify your answer to address Scientific Critic's most recent feedback. Remember that your ultimate goal is to make improvements that better address the agenda.

## Medicinal Chemist

To address the feedback provided by the Scientific Critic and ensure alignment with the agenda, I will expand on the initial response by incorporating additional details and justifications. This will include a clearer connection to the clinical value and machine learning integration, as well as addressing risk management and decision points.

### Revised Experiment Setup

```plaintext
ExperimentFluorescencePolarization[
  mySamples,
  ExcitationWavelength -> (485 * Nanometer),
  EmissionWavelength -> (520 * Nanometer),
  Gain -> (50 * Percent),
  PlateReaderMix -> True,
  PlateReaderMixTime -> (1 * Minute),
  PlateReaderMixRate -> (700 * RPM),
  Temperature -> (37 * Celsius),
  NumberOfReplicates -> 3
]
```

### Enhanced Justifications and Context

1. **Excitation and Emission Wavelengths**
   - **Default Value**: Automatic
   - **Chosen Values**: 485 Nanometers (Excitation), 520 Nanometers (Emission)
   - **Justification**: These wavelengths are optimal for fluorescein, a common fluorophore used in fluorescence polarization assays. This choice ensures high sensitivity and specificity in detecting peptide-receptor interactions, which is crucial for validating machine learning predictions about binding affinities and interaction dynamics.

2. **Gain**
   - **Default Value**: Automatic (90% if an adjustment sample is provided)
   - **Chosen Value**: 50 Percent
   - **Justification**: Setting the gain to 50% prevents detector saturation, ensuring accurate measurement of polarization changes. This is particularly important for distinguishing between bound and unbound states of peptides, which directly informs the refinement of machine learning models predicting binding efficacy.

3. **PlateReaderMix and Related Options**
   - **Default Values**: Automatic
   - **Chosen Values**: True (Mix), 1 Minute (MixTime), 700 RPM (MixRate)
   - **Justification**: Ensures thorough mixing of samples, which is critical for consistent fluorescence readings. This consistency is necessary for reliable data that can be used to validate and refine machine learning models.

4. **Temperature**
   - **Default Value**: Ambient
   - **Chosen Value**: 37 Celsius
   - **Justification**: Conducting the experiment at physiological temperature maintains the biological relevance of the assay, particularly for peptides designed to interact with human proteins. This relevance is essential for translating computational predictions into clinically viable therapeutics.

5. **Number of Replicates**
   - **Default Value**: Null
   - **Chosen Value**: 3
   - **Justification**: Triplicate measurements increase data reliability and allow for statistical validation of results, which is crucial for assessing the accuracy of machine learning predictions.

### Integration with Machine Learning

- **Data Utilization**: The fluorescence polarization data will be used to validate machine learning predictions regarding peptide binding affinities and structural dynamics. Discrepancies between predicted and observed data will inform iterative model refinement.
- **Feedback Loop**: Establish a bi-weekly feedback loop where experimental results are used to adjust computational models, enhancing prediction accuracy and guiding subsequent experimental designs.

### Risk Management and Contingency Plans

- **Potential Risks**: Inaccurate fluorescence readings due to sample evaporation or instrument variability.
- **Mitigation Strategies**: Use of plate seals to minimize evaporation and regular calibration of the plate reader. If results are inconsistent, additional replicates or alternative fluorophores may be considered.

### Decision Points

- **Data Analysis**: If the fluorescence polarization results do not meet expected thresholds (e.g., significant polarization change indicating binding), the peptide design will be revisited using updated machine learning models.
- **Iterative Refinement**: Results will guide the selection of peptide modifications or alternative targets, ensuring a focused approach to achieving high clinical value.

By incorporating these detailed justifications and strategies, the revised response better addresses the agenda's goals of clinical relevance, impactful machine learning application, and efficient use of ECL for experimental validation.

## User

Scientific Critic, please critique Medicinal Chemist's most recent answer. In your critique, suggest improvements that directly address the agenda and any agenda questions. Prioritize simple solutions over unnecessarily complex ones, but demand more detail where detail is lacking. Additionally, validate whether the answer strictly adheres to the agenda and any agenda questions and provide corrective feedback if it does not. Only provide feedback; do not implement the answer yourself.

## Scientific Critic

The Medicinal Chemist's revised response shows significant improvement in addressing the agenda, particularly in integrating machine learning and providing detailed justifications for the experimental setup. However, there are still areas that could benefit from further refinement and detail:

1. **Clinical Value Connection**:
   - While the response mentions the biological relevance of conducting experiments at physiological temperature, it could further elaborate on how the specific peptide-receptor interactions studied are expected to contribute to clinical outcomes. For instance, how do these interactions relate to the disease targets previously identified (e.g., GLP-1 receptor for diabetes)?

2. **Machine Learning Integration**:
   - The feedback loop is mentioned, but more detail on the specific machine learning models or algorithms used would be beneficial. How are these models trained, and what specific predictions are they making that are being validated by the fluorescence polarization data? This would provide a clearer picture of the scientific impact.

3. **Risk Management**:
   - The response identifies potential risks and mitigation strategies, but it could be more specific about the contingency plans. For example, if evaporation is a concern, what specific measures (e.g., using a particular type of plate seal) will be implemented? Additionally, what are the criteria for deciding when to switch to alternative fluorophores?

4. **Decision Points**:
   - The decision points are outlined, but the criteria for success or failure could be more quantitative. For example, what specific thresholds or metrics will determine whether a peptide design is revisited? This would enhance the transparency and reproducibility of the decision-making process.

5. **Simplification and Clarity**:
   - While the response is detailed, it could be streamlined by focusing on the most critical aspects of the experiment that directly impact the agenda goals. For instance, emphasizing the direct link between experimental results and machine learning model refinement could be more succinctly presented.

6. **Adherence to Agenda**:
   - The response generally adheres to the agenda, but it could more explicitly address the timeline constraint of a 3-month limit for experiments. How does the proposed setup ensure that the experiments will be completed within this timeframe?

By addressing these points, the Medicinal Chemist can further refine the response to ensure it fully meets the agenda's requirements and provides a clear, actionable plan for implementing the `ExperimentFluorescencePolarization` protocol.

## User

Medicinal Chemist, please modify your answer to address Scientific Critic's most recent feedback. Remember that your ultimate goal is to make improvements that better address the agenda.

## Medicinal Chemist

To further refine the response and address the feedback provided by the Scientific Critic, I will incorporate additional details and clarifications, focusing on clinical value, machine learning integration, risk management, decision points, and adherence to the timeline constraint.

### Revised Experiment Setup

```plaintext
ExperimentFluorescencePolarization[
  mySamples,
  ExcitationWavelength -> (485 * Nanometer),
  EmissionWavelength -> (520 * Nanometer),
  Gain -> (50 * Percent),
  PlateReaderMix -> True,
  PlateReaderMixTime -> (1 * Minute),
  PlateReaderMixRate -> (700 * RPM),
  Temperature -> (37 * Celsius),
  NumberOfReplicates -> 3
]
```

### Enhanced Justifications and Context

1. **Clinical Value Connection**
   - **Disease Relevance**: The fluorescence polarization assay is designed to study peptide interactions with clinically relevant targets such as the GLP-1 receptor for Type 2 Diabetes. By validating these interactions, we aim to develop peptides that can modulate these targets effectively, potentially leading to new therapeutic options with improved specificity and reduced side effects.

2. **Machine Learning Integration**
   - **Model Details**: We are using machine learning models such as neural networks and support vector machines to predict peptide binding affinities and structural dynamics. These models are trained on datasets from PDB and BindingDB, focusing on known peptide-protein interactions. The fluorescence polarization data will validate these predictions, allowing us to refine the models by adjusting parameters and incorporating new data.

3. **Risk Management**
   - **Evaporation Mitigation**: To address evaporation concerns, we will use specialized plate seals designed for fluorescence assays. If results show variability due to evaporation, we will consider using alternative plate formats that minimize surface area exposure.
   - **Alternative Fluorophores**: If the chosen fluorophore does not provide adequate signal, we will evaluate alternatives such as Alexa Fluor dyes, which offer higher photostability and brightness.

4. **Decision Points**
   - **Quantitative Criteria**: Success will be determined by achieving a polarization change indicative of binding, with a threshold set at a minimum of 20 mP units. If this threshold is not met, the peptide design will be revisited using updated machine learning predictions to optimize binding affinity and specificity.

5. **Simplification and Clarity**
   - **Focus on Key Aspects**: The primary focus is on validating machine learning predictions through experimental data, ensuring that each step directly contributes to refining peptide design and enhancing therapeutic potential.

6. **Adherence to Agenda and Timeline**
   - **3-Month Limit**: The experimental setup is designed to be completed within the 3-month timeframe by prioritizing high-throughput assays and efficient data analysis workflows. Regular progress reviews will ensure that the timeline is adhered to, with adjustments made as necessary to maintain momentum.

By incorporating these detailed justifications and strategies, the revised response better addresses the agenda's goals of clinical relevance, impactful machine learning application, and efficient use of ECL for experimental validation within the specified timeframe.

## User

Scientific Critic, please critique Medicinal Chemist's most recent answer. In your critique, suggest improvements that directly address the agenda and any agenda questions. Prioritize simple solutions over unnecessarily complex ones, but demand more detail where detail is lacking. Additionally, validate whether the answer strictly adheres to the agenda and any agenda questions and provide corrective feedback if it does not. Only provide feedback; do not implement the answer yourself.

## Scientific Critic

The Medicinal Chemist's revised response demonstrates a more comprehensive approach to addressing the agenda, with improved integration of clinical value, machine learning, and risk management. However, there are still areas where further refinement and detail could enhance the response:

1. **Clinical Value Connection**:
   - The response now links the fluorescence polarization assay to specific disease targets, such as the GLP-1 receptor for Type 2 Diabetes. However, it could further elaborate on how the results of this experiment will directly impact clinical outcomes or the development of therapeutic candidates. For instance, what specific clinical benefits are anticipated from modulating these targets with peptides?

2. **Machine Learning Integration**:
   - While the response mentions the use of neural networks and support vector machines, it could benefit from more detail on how these models are specifically tailored to the peptide interactions being studied. Additionally, it would be helpful to outline how the feedback from experimental data will be quantitatively integrated into model updates.

3. **Risk Management**:
   - The response addresses evaporation and alternative fluorophores, but it could include more specific criteria for when these contingencies will be triggered. For example, what level of signal variability would necessitate switching to an alternative fluorophore?

4. **Decision Points**:
   - The response provides a quantitative threshold for polarization change, which is a positive addition. However, it could also specify what constitutes a successful validation of machine learning predictions beyond just meeting this threshold. Are there other metrics or outcomes that will guide decision-making?

5. **Simplification and Clarity**:
   - The response is generally clear, but it could be further streamlined by focusing on the most critical aspects of the experiment that directly impact the agenda goals. For example, emphasizing the iterative nature of the feedback loop between experimental results and machine learning model refinement could be more succinctly presented.

6. **Adherence to Agenda and Timeline**:
   - The response addresses the 3-month limit, but it could provide more detail on the specific steps or checkpoints that will ensure the timeline is met. For instance, what are the key milestones, and how will progress be monitored?

By addressing these points, the Medicinal Chemist can further refine the response to ensure it fully meets the agenda's requirements and provides a clear, actionable plan for implementing the `ExperimentFluorescencePolarization` protocol.

## User

Medicinal Chemist, please modify your answer to address Scientific Critic's most recent feedback. Remember that your ultimate goal is to make improvements that better address the agenda.

## Medicinal Chemist

To further refine the response and address the feedback provided by the Scientific Critic, I will incorporate additional details and clarifications, focusing on clinical value, machine learning integration, risk management, decision points, and adherence to the timeline constraint.

### Revised Experiment Setup

```plaintext
ExperimentFluorescencePolarization[
  mySamples,
  ExcitationWavelength -> (485 * Nanometer),
  EmissionWavelength -> (520 * Nanometer),
  Gain -> (50 * Percent),
  PlateReaderMix -> True,
  PlateReaderMixTime -> (1 * Minute),
  PlateReaderMixRate -> (700 * RPM),
  Temperature -> (37 * Celsius),
  NumberOfReplicates -> 3
]
```

### Enhanced Justifications and Context

1. **Clinical Value Connection**
   - **Disease Relevance**: The fluorescence polarization assay is designed to study peptide interactions with clinically relevant targets such as the GLP-1 receptor for Type 2 Diabetes. By validating these interactions, we aim to develop peptides that can modulate these targets effectively, potentially leading to new therapeutic options with improved specificity and reduced side effects. The anticipated clinical benefits include enhanced glucose regulation and reduced risk of hypoglycemia compared to existing therapies.

2. **Machine Learning Integration**
   - **Model Details**: We are using machine learning models such as neural networks and support vector machines to predict peptide binding affinities and structural dynamics. These models are trained on datasets from PDB and BindingDB, focusing on known peptide-protein interactions. The fluorescence polarization data will validate these predictions, allowing us to refine the models by adjusting parameters and incorporating new data. Specifically, the data will be used to update model weights and improve prediction accuracy through techniques like backpropagation.

3. **Risk Management**
   - **Evaporation Mitigation**: To address evaporation concerns, we will use specialized plate seals designed for fluorescence assays. If results show variability due to evaporation, we will consider using alternative plate formats that minimize surface area exposure. A variability threshold of 10% in signal intensity will trigger the use of alternative measures.
   - **Alternative Fluorophores**: If the chosen fluorophore does not provide adequate signal, we will evaluate alternatives such as Alexa Fluor dyes, which offer higher photostability and brightness. A signal-to-noise ratio below 3:1 will prompt this evaluation.

4. **Decision Points**
   - **Quantitative Criteria**: Success will be determined by achieving a polarization change indicative of binding, with a threshold set at a minimum of 20 mP units. If this threshold is not met, the peptide design will be revisited using updated machine learning predictions to optimize binding affinity and specificity. Additionally, successful validation will be indicated by a correlation coefficient of at least 0.8 between predicted and observed binding affinities.

5. **Simplification and Clarity**
   - **Focus on Key Aspects**: The primary focus is on validating machine learning predictions through experimental data, ensuring that each step directly contributes to refining peptide design and enhancing therapeutic potential. The iterative feedback loop will be emphasized, with bi-weekly reviews to assess model performance and guide experimental adjustments.

6. **Adherence to Agenda and Timeline**
   - **3-Month Limit**: The experimental setup is designed to be completed within the 3-month timeframe by prioritizing high-throughput assays and efficient data analysis workflows. Key milestones include completing initial data collection within the first month, model refinement and additional experiments in the second month, and final validation and reporting in the third month. Progress will be monitored through weekly team meetings and milestone reviews.

By incorporating these detailed justifications and strategies, the revised response better addresses the agenda's goals of clinical relevance, impactful machine learning application, and efficient use of ECL for experimental validation within the specified timeframe.

